Health-related quality of life of unrelated bone marrow donors in Japan by Mina Nishimori, Yoshitsugu Yamada, Keiko Hoshi, Yuichi Akiyama, Yasutaka Hoshi,

Slides:

Advertisements

Similar presentations

Validation of a flow cytometric scoring system as a prognostic indicator for posttransplantation outcome in patients with myelodysplastic syndrome by Bart.

Advertisements

Effects of HLA Allele and Killer Immunoglobulin-Like Receptor Ligand Matching on Clinical Outcome in Leukemia Patients Undergoing Transplantation With.

by Robert A. Kyle, Morie A. Gertz, Philip R. Greipp, Thomas E

Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene by A.

Proportion of patients reporting scores ≥age-matched and gender-matched normative PRO values at baseline and 24 weeks in the (A) AMBITION and (B) ADACTA.

Telomerase and telomere length in multiple myeloma: correlations with disease heterogeneity, cytogenetic status, and overall survival by Kai-Da Wu, Lisa.

Molecular Typing Shows a High Level of HLA Class I Incompatibility in Serologically Well Matched Donor/Patient Pairs: Implications for Unrelated Bone Marrow.

A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.

Nonmyeloablative conditioning for relapsed follicular lymphoma

Symptomatic and Incidental Venous Thromboembolic Disease Are Both Associated With Mortality In Patients With Prostate Cancer by Shruti Chaturvedi, Surbhi.

Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program by Michael.

Mutagenic potential of temozolomide in bone marrow cells in vivo

Full hematopoietic engraftment after allogeneic bone marrow transplantation without cytoreduction in a child with severe combined immunodeficiency by Ronald.

Psychosocial Correlates of Symptoms in Functional Dyspepsia

by Adrienne Lee, Steven K. Boyd, Gregory Kline, and Man-Chiu Poon

Mean changes in the Short Form-36 subscales from baseline values for combined pulmonary fibrosis and emphysema (CPFE) (n=16), and chronic obstructive pulmonary.

ROCK and Rho(ll) in bone marrow

Patients’ priorities in selecting chronic lymphocytic leukemia treatments by Carol Mansfield, Anthony Masaquel, Jessie Sutphin, Elisa Weiss, Meghan Gutierrez,

by Giridharan Ramsingh, Meagan A. Jacoby, Jin Shao, Rigoberto E

A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is.

Lung Resection Improves the Quality of Life of Patients With Symptomatic Bronchiectasis Camilla Carlini Vallilo, MS, Ricardo Mingarini Terra, MD, PhD,

Health-Related Quality-of-Life Measures: Evidence from Tunisian Population Using the SF-12 Health Survey Moheddine Younsi, PhD Value in Health Regional.

The Impact of Pain Management on Quality of Life

Five-year real world outcomes of GeoForm ring implantation in patients with ischemic mitral regurgitation Tomasz A. Timek, MD, Robert L. Hooker, MD,

Baseline Comorbidity Associated With the Short-Term Effects of Exercise Intervention on Quality of Life in the Japanese Older Population: An Observational.

Quality of Life and Adaptation in People With Spinal Cord Injury: Response Shift Effects From 1 to 5 Years Postinjury Carolyn E. Schwartz, ScD, Brian.

Against the odds: Long-term outcome of drastic-risk cardiac surgery

Long-term acquisition of allergen-specific IgE and asthma following allogeneic bone marrow transplantation from allergic donors by Teal S. Hallstrand,

Lentiviral-mediated RNAi inhibition of Sbds in murine hematopoietic progenitors impairs their hematopoietic potential by Amy S. Rawls, Alyssa D. Gregory,

Onset of thymic recovery and plateau of thymic output are differentially regulated after stem cell transplantation in children Matthias Eyrich, Gernot.

Poorer sleep quality among adult patients with pectus excavatum in Taiwan: A pilot study Yeung-Leung Cheng, MD, PhD, Chou-Chin Lan, MD, PhD, Yao-Kuang.

Health-Related Quality of Life Outcome After On-Pump Versus Off-Pump Coronary Artery Bypass Graft Surgery: A Prospective Randomized Study Reza Motallebzadeh,

High Risk HLA Allele for Severe Acute Graft-Versus-Host-Disease and Mortality in Unrelated Donor Hematopoietic Stem Cell Transplantation Satoko Morishima,

Significance of Ethnicity in the Risk of Acute Graft-versus-Host Disease and Leukemia Relapse after Unrelated Donor Hematopoietic Stem Cell Transplantation

Health Status Rated With the Medical Outcomes Study 36-Item Short-Form Health Survey After Spinal Cord Injury Mark J. Haran, Bonsan B. Lee, Madeleine.

Responsiveness and clinically important differences for the WOMAC and SF-36 after total knee replacement A. Escobar, M.D., J.M. Quintana, Ph.D., A. Bilbao,

Quantity of clot lysed after catheter-directed thrombolysis for iliofemoral deep venous thrombosis correlates with postthrombotic morbidity Nina K. Grewal,

Long-Term Health-Related Quality of Life After Maze Surgery for Atrial Fibrillation Catharina Lundberg, MD, Anders Albåge, MD, PhD, Carina Carnlöf, RN,

Mu Qin et al. JACEP 2017;j.jacep

by Achille Iolascon, Hermann Heimpel, Anders Wahlin, and Hannah Tamary

Allogeneic Bone Marrow Transplantation from Unrelated Human T-Cell Leukemia Virus- I–negative Donors for Adult T-Cell Leukemia/Lymphoma: Retrospective.

(A) Quality of life scores in individuals with and without constipation. (A) Quality of life scores in individuals with and without constipation. (B) Quality.

Correlations between observed patient-reported outcomes and disease activity scores at week 24. Correlations between observed patient-reported outcomes.

Statistical Considerations in Studies of Late Effects in HCT

Health-related quality of life in survivors of open ruptured abdominal aortic aneurysm repair: A matched, controlled cohort study Andrew B. Hill, MDCM,

Seth D. Crockett, Quinn K. Lippmann, Evan S. Dellon, Nicholas J

Hematopoietic Engraftment in Recipients of Unrelated Donor Umbilical Cord Blood Is Affected by the CD34+ and CD8+ Cell Doses Seitaro Terakura, Eiichi.

Recipient PTPN22 −1123 C/C Genotype Predicts Acute Graft-versus-Host Disease after HLA Fully Matched Unrelated Bone Marrow Transplantation for Hematologic.

Effects of HLA Allele and Killer Immunoglobulin-Like Receptor Ligand Matching on Clinical Outcome in Leukemia Patients Undergoing Transplantation With.

The Effect of Unrelated Donor Marrow Transplantation on Health-Related Quality of Life: A Report of the Unrelated Donor Marrow Transplantation Trial (T-Cell.

SF-36 domain scores at baseline and 24 weeks compared with age-matched and gender-matched normative values in the (A) AMBITION and (B) ADACTA trial populations.

ID Dr. Natālija Nikrus, Dr. Maija Vikmane, Prof. Oskars Kalējs

Mean individual and summative SF-36 V2 scores before and 3 months after ablation. Mean individual and summative SF-36 V2 scores before and 3 months after.

The Impact of Donor Type on Long-Term Health Status and Quality of Life after Allogeneic Hematopoietic Stem Cell Transplantation for Childhood Acute Leukemia:

Patient-reported quality of life after abdominal aortic aneurysm surgery: A prospective comparison of endovascular and open repair Badr Aljabri, MD,

Cord blood transplantation recapitulates fetal ontogeny with a distinct molecular signature that supports CD4+ T-cell reconstitution by Prashant Hiwarkar,

Percentages of patients reporting improvements from baseline ≥minimum clinically important difference (MCID) and number needed to treat (NNT) in (A) patient-reported.

Pain. Pain. (A) Skeletal pain experienced by bone marrow (BM) and peripheral blood stem cell (PBSC) donors at baseline, during the pericollection period,

Mean Short-Form 36 (SF-36) domain scores at baseline and 6 months in patients receiving active or placebo corticosteroids, cDMARDs or TNFis. Mean Short-Form.

Spydergram of mean SF-36 domain scores at baseline and weeks 12 (A) and 24 (B) for sarilumab 150 mg and 200 mg+csDMARDs compared with placebo+csDMARDs.

Quality of life in patients with no-option critical limb ischemia underlines the need for new effective treatment Ralf W. Sprengers, MD, Martin Teraa,

Spider plot of the unstandardised SF-36v2 subscales, comparing our HCM population with the mean for the general population (aged 45–54 years). Spider plot.

Quality of life after aortic valve replacement with tissue and mechanical implants Artyom Sedrakyan, MD, Patricia Hebert, PhD, Viola Vaccarino, MD, PhD,

J. J. Smith, FRCS, A. M. Garratt, PhD, M. Guest, FRCS, R. M

The ITGAL promoter is methylated in fibroblasts but not T cells

LPA groups display vastly different outcomes.

Survival of children with sickle cell disease

Shifts in site of hematopoiesis during mouse and human development.

Optimal treatment strategies for hemophilia: achievements and limitations of current prophylactic regimens by Johannes Oldenburg Blood Volume 125(13):

Post hoc analysis of differences from placebo in the percentage of patients reporting improvements ≥MCID at week 24. Post hoc analysis of differences from.

Presentation transcript:

Health-related quality of life of unrelated bone marrow donors in Japan by Mina Nishimori, Yoshitsugu Yamada, Keiko Hoshi, Yuichi Akiyama, Yasutaka Hoshi, Yasuo Morishima, Masahiro Tsuchida, Shunichi Fukuhara, and Yoshihisa Kodera Blood Volume 99(6):1995-2001 March 15, 2002 ©2002 by American Society of Hematology

Changes in LS means of the SF-36 deviation scores Changes in LS means of the SF-36 deviation scores.The estimated LS means and 95% confidence limits are shown for the deviation scores on all 8 SF-36 scales, for different time points (before BMH, and 1 week and 3 months after discharge). Changes in LS means of the SF-36 deviation scores.The estimated LS means and 95% confidence limits are shown for the deviation scores on all 8 SF-36 scales, for different time points (before BMH, and 1 week and 3 months after discharge). The reference line “zero” indicates the Japanese national norm. Before BMH, all LS means were significantly higher than the Japanese national norms. One week after discharge, LS means of PF, RP, and BP were approximately 1 SD lower than the national norm (P < .001). However, LS means of GH and MH remained more than 0.5 SD higher than the national norm (P < .001). By 3 months after discharge, all LS means had returned to their pre-BMH levels. The number of donors who did not return to pre-BMH levels at 3 months was 36 for PF, 38 for RP, and 82 for BP. *P < .001 (compared with pre-BMH value; Tukey procedure). †P < .001 (compared with the Japanese national norm; Student's t test). Mina Nishimori et al. Blood 2002;99:1995-2001 ©2002 by American Society of Hematology